Skip to main content

Ahlberg Gregory A's Form 4 filing

Abbott Laboratories (ABT) · filed Nov 17, 2021

Accession no.
0001415889-21-005270
Filed
Nov 17, 2021
Trade date
Nov 15, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.31M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ahlberg Gregory ACIK 0001826317Officer (SENIOR VICE PRESIDENT)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2021Common shares without par valueMOption exerciseAcquired+6,000$48.98+$293,88019,825Direct
Nov 15, 2021Common shares without par valueSSaleDisposed−3,905$130.00−$507,65015,920Direct
Nov 15, 2021Common shares without par valueMOption exerciseAcquired+30,935$59.94+$1,854,243.946,855Direct
Nov 15, 2021Common shares without par valueSSaleDisposed−21,568$130.00−$2,803,84025,287Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 15, 2021Common SharesMOption exerciseDisposed−6,000$0.00$00Direct
Nov 15, 2021Common SharesMOption exerciseDisposed−30,935$0.00$015,468Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

Read the full filing on SEC EDGAR (opens in a new tab)